Edition:
United States

Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

253.35USD
12 Dec 2017
Change (% chg)

$0.17 (+0.07%)
Prev Close
$253.18
Open
$253.18
Day's High
$253.40
Day's Low
$252.01
Volume
28,216
Avg. Vol
38,141
52-wk High
$272.88
52-wk Low
$178.00

Select another date:

Tue, Nov 28 2017

BRIEF-Bio-Rad Authorizes New $250 Million Share Repurchase Program

* BIO-RAD AUTHORIZES NEW $250 MILLION SHARE REPURCHASE PROGRAM

BRIEF-Bio Rad Laboratories reports Q3 earnings per share $0.91

* Bio Rad Laboratories Inc reports third-quarter 2017 financial results

BRIEF-U.S. ITC to probe certain 10X Genomics devices after Bio-Rad complaint

* U.S. U.S. International Trade Commission says it will investigate certain microfluidic devices by 10x Genomics Inc after complaint by Bio-rad Laboratories Inc and Lawrence Livermore National Security LLC. Source text for Eikon: Further company coverage: (Reporting By Susan Heavey)

BRIEF-Bio-Rad reports Q2 earnings per share $0.17

* Q2 earnings per share view $0.56 -- Thomson Reuters I/B/E/S

Bio-Rad brings patent case against upstart rival 10X Genomics

The life sciences company Bio-Rad Laboratories Inc on Monday accused its upstart rival 10X Genomics of selling DNA analysis machines that infringe its patents.

BRIEF-Virbac signs a research agreement with Bio-Gene

* VIRBAC SA - VIRBAC SIGNS A RESEARCH AGREEMENT WITH BIO-GENE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: